BioSpace News Archive

Pharm Country

Thomas Jefferson University Launches the Nation’s Only University-Based Cannabis Science Graduate Certificate Programs to Prepare Healthcare and Industry Professionals for the Fast-Growing Field

With 30 states now allowing the use of medical marijuana, the multi-billion dollar legal cannabis industry is projected to be one of the fastest-growing sectors of the U.S. economy in the next decade.

July 5, 2018
·
5 min read
Pharm Country

MTF Biologics Joins Lineup at American Orthopaedic Society for Sports Medicine 2018 Annual Meeting

World’s largest tissue bank to unveil new cartilage allograft and showcase portfolio of innovations for sports medicine

July 5, 2018
·
2 min read
Deals

Verastem Oncology Announces Inducement Grants of 201,500 Shares Under Nasdaq Listing Rule 5635(c)(4)

Verastem, Inc. announced the grant of stock options to nine new employees to purchase an aggregate of 201,500 shares of Verastem Oncology’s common stock.

July 5, 2018
·
2 min read
Business

AMN Healthcare to Host Second Quarter 2018 Earnings Conference Call on Thursday, August 2, 2018

AMN Healthcare Services, Inc. will host a conference call to discuss its second quarter 2018 financial results on Thursday, August 2, 2018 at 5:00 p.m. Eastern Time.

July 5, 2018
·
3 min read
Business

Acceleron Appoints Robert K. Zeldin, M.D., Chief Medical Officer

Acceleron Pharma Inc. announced the appointment of Robert K. Zeldin, M.D., as Chief Medical Officer (CMO). Dr. Zeldin brings to Acceleron more than two decades of clinical, regulatory

July 5, 2018
·
6 min read
Business

CNL HEALTHCARE PROPERTIES ANNOUNCES SPECIAL COMMITTEE, NAMES FINANCIAL ADVISORS TO CONSIDER STRATEGIC ALTERNATIVES

CNL Healthcare Properties announced that the board of directors has appointed a special committee of its independent board members to evaluate strategic alternatives to provide liquidity to shareholders, and has now named financial advisors to assist in the process.

July 5, 2018
·
2 min read
Pharm Country

NetworkNewsWire Announces Publication on Innovative Advancements in Med Tech Diagnostics

NetworkNewsWire announces the publication of an editorial featuring Zenosense

July 5, 2018
·
3 min read
Biotech Beach

Capricor Therapeutics to Present at PPMD Annual ConferencePoster Presentation on Pre-clinical Research of CAP-2003 in Disease Model of Duchenne Muscular Dystrophy

Capricor Therapeutics’ (NASDAQ:CAPR) chief medical officer, Deborah Ascheim, M.D., will present a corporate overview at the Parents Project Muscular Dystrophy (PPMD) 2018 Annual Conference on June 29 in Scottsdale, AZ.

July 5, 2018
·
5 min read
Deals

Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Pricing of Initial Public Offering

Neuronetics, Inc. announced today the pricing of its initial public offering of 5.5 million shares of its common stock at a public offering price of $17.00 per share.

July 5, 2018
·
3 min read
Drug Development

Cocrystal Pharma Commences Enrollment and Initiates Patient Dosing in Phase 2a Study Evaluating CC-31244 for the Treatment of HCV

Cocrystal Pharma, Inc. announced the commencement of enrollment and initiation of patient dosing in its Phase 2a clinical study evaluating CC-31244 for the treatment of hepatitis C virus (HCV)-infected individuals.

July 5, 2018
·
6 min read